Schonewille Henk, Brand Anneke
Sanquin Bloodbank, Southwest Region, Leiden, The Netherlands.
Br J Haematol. 2005 Apr;129(1):151-6. doi: 10.1111/j.1365-2141.2005.05408.x.
Leucodepletion has been shown to reduce human leucocyte antigen immunization, but studies on the effect of leucodepletion on red cell alloimmunization reported discordant results. We conducted a retrospective multicentre study to determine whether prestorage filter leucodepletion alters the development of clinically significant red blood cell alloimmunization against the Rhesus, Kell, Duffy, Kidd and MSs blood group systems. Two periods were investigated, 2 years before and 2 years after universal leucodepletion. Comparisons were made between the transfused patient cohorts. To control for changes not related to leucoreduction, we compared antibody incidence with antibody prevalence in the two study periods. Newly detected antibodies (n = 4770) were found in 4115 patients from 19 participating hospitals. Of these, 857 antibodies in 659 patients were because of transfusions given in the study periods. The immunization risk was 0.13% for both periods. No differences were found regarding incidence of new antibodies, nor for patients regarding age, sex, previous antibodies, multiple antibodies, additional antibodies, number of transfusions, transfusions episodes and days from transfusion to date of immunization. In conclusion, compared with buffy-coat leucoreduction, universal prestorage filter leucodepletion did not alter the development of clinically significant red blood cell alloimmunization.
白细胞去除术已被证明可减少人类白细胞抗原免疫,但关于白细胞去除术对红细胞同种免疫影响的研究报告结果不一致。我们进行了一项回顾性多中心研究,以确定储存前滤器白细胞去除术是否会改变针对恒河猴、凯尔、达菲、基德和MSS血型系统的具有临床意义的红细胞同种免疫的发生情况。研究了两个时期,即普遍白细胞去除术实施前2年和实施后2年。对输血患者队列进行了比较。为了控制与白细胞减少无关的变化,我们比较了两个研究时期的抗体发生率和抗体流行率。在19家参与研究的医院的4115名患者中发现了4770种新检测到的抗体。其中,659名患者中的857种抗体是由于在研究期间进行的输血。两个时期的免疫风险均为0.13%。在新抗体发生率方面未发现差异,在患者的年龄、性别、既往抗体、多种抗体、额外抗体、输血量、输血次数以及从输血到免疫日期的天数方面也未发现差异。总之,与去白细胞层白细胞减少术相比,普遍的储存前滤器白细胞去除术并未改变具有临床意义的红细胞同种免疫的发生情况。